Innovation

1 patent family — focus: Chemistry & metallurgy; filing pace slowing. Cited 8 times.

Year	Filings
2023	1

Investor mix

5 investors on record; lead investors include National Small and Medium-sized Enterprise Development Fund, Zhejiang Haibang Investment Management, ihubo, Liyi Medicine.

Investor type	Count	Share
Venture capital	1	20%
Private equity	2	40%
Other / undisclosed	2	40%